Cresco Labs (CRLBF) Non-cash Items (2023 - 2024)
Cresco Labs (CRLBF) reported Non-cash Items of $24000.0 for Q3 2024, down 92.52% on a YoY basis from $321000.0 in Q4 2023, and little changed quarter-over-quarter from $24000.0 in Q2 2024.
Cresco Labs (CRLBF) Non-cash Items (2023 - 2024) Analysis & Trends
Cresco Labs has reported Non-cash Items for 2 years, with the latest figure at $24000.0 in Q3 2024.
- For the quarter ending Q3 2024, Non-cash Items fell 92.52% year-over-year to $24000.0; the trailing twelve-month figure through Sep 2024 stood at $24000.0 (down 92.52% YoY), and the FY2023 full-year result was $209000.0, changed N/A from the prior year.
- Non-cash Items for Q3 2024 stood at $24000.0, roughly flat from $24000.0 in the prior quarter.
- The five-year high for Non-cash Items was $321000.0 in Q2 2023, with the low at $24000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Sep 30, 2023 | 321,000.00 |
| Sep 30, 2023 | 321,000.00 |
| Jun 30, 2023 | 321,000.00 |
| Jun 30, 2023 | 321,000.00 |
| Mar 31, 2023 | 92,000.00 |
| Mar 31, 2023 | 92,000.00 |